KELLY VIAL: Open Payments
NPI 1447486295 · SOUTH LAKE TAHOE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 11 payments from 9 companies in 2025. Trend: 2023 $250 · 2024 $260 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $41 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
| Alkermes, Inc. | 1 | $34 |
| Novo Nordisk Inc | 1 | $29 |
| PFIZER INC. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Indivior Inc. | 1 | $14 |
Products named: JOURNAVX, VIVITROL, Wegovy, PREVNAR 20, ROTATEQ, BEXSERO, MOUNJARO, Dexcom G6 Transmitter.
Industry payments across CA — which companies pay providers there.
